Hologic, Inc. Appoints Wayde McMillan to Board of Directors

MARLBOROUGH, Mass. – April 4, 2025 – Hologic, Inc. (NASDAQ: HOLX) announced the appointment of Wayde McMillan, current Chief Financial Officer of Solventum Corporation, to its Board of Directors, effective April 4, 2025. This move increases the size of Hologic’s board from eight to nine members.

Mr. McMillan will also serve on the Audit and Finance Committee. As a non-employee director, he will receive standard director compensation as outlined in Hologic’s latest proxy statement. He is also expected to sign the company’s standard indemnification agreement for directors.

There are no prior arrangements or transactions involving Mr. McMillan that require disclosure under SEC rules. His appointment supports Hologic’s ongoing commitment to enhancing its financial and governance expertise at the board level.